Page 1 | Search Results | Hematology, ASH Education Program

1-20 of 104

Sort by

Sort Order Select

Journal Articles

Primary immunodeficiencies: novel genes and unusual presentations

Luigi D. Notarangelo, Gulbu Uzel, V. Koneti Rao

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 443–448.

https://doi.org/10.1182/hematology.2019000051

Published: 2019

Journal Articles

Genetic predisposition to MDS: diagnosis and management

Elissa Furutani, Akiko Shimamura

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 110–119.

https://doi.org/10.1182/hematology.2019000021

Published: 2019

Journal Articles

JAK2 (and other genes) be nimble with MPN diagnosis, prognosis, and therapy

Michele Ciboddo, Ann Mullally

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 110–117.

https://doi.org/10.1182/asheducation-2018.1.110

Published: 2018

Journal Articles

A brief, but comprehensive, guide to clonal evolution in aplastic anemia

Daria V. Babushok

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 457–466.

https://doi.org/10.1182/asheducation-2018.1.457

Published: 2018

Journal Articles

Potential new approaches to the management of the Hb Bart’s hydrops fetalis syndrome: the most severe form of α-thalassemia

Andrew J. King, Douglas R. Higgs

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 353–360.

https://doi.org/10.1182/asheducation-2018.1.353

Published: 2018

Journal Articles

The mutational landscape of chronic lymphocytic leukemia and its impact on prognosis and treatment

Gianluca Gaidano, Davide Rossi

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 329–337.

https://doi.org/10.1182/asheducation-2017.1.329

Published: 2017

Journal Articles

Follicular lymphoma: are we ready for a risk-adapted approach?

Brad S. Kahl

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 358–364.

https://doi.org/10.1182/asheducation-2017.1.358

Published: 2017

Journal Articles

Acquired ribosomopathies in leukemia and solid tumors

Adrianna Vlachos

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 716–719.

https://doi.org/10.1182/asheducation-2017.1.716

Published: 2017

Journal Articles

Toward personalized treatment in Waldenström macroglobulinemia

Jorge J. Castillo, Steven P. Treon

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 365–370.

https://doi.org/10.1182/asheducation-2017.1.365

Published: 2017

Journal Articles

Uncoding the genetic heterogeneity of myelodysplastic syndrome

R. Coleman Lindsley

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 447–452.

https://doi.org/10.1182/asheducation-2017.1.447

Published: 2017

Journal Articles

Diagnosing von Willebrand disease: genetic analysis

Anne Goodeve

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 678–682.

https://doi.org/10.1182/asheducation-2016.1.678

Published: 2016

Journal Articles

Aplastic anemia and clonal evolution: germ line and somatic genetics

Akiko Shimamura

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 74–82.

https://doi.org/10.1182/asheducation-2016.1.74

Published: 2016

Journal Articles

Ph-like acute lymphoblastic leukemia

Thai Hoa Tran, Mignon L. Loh

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 561–566.

https://doi.org/10.1182/asheducation-2016.1.561

Published: 2016

Journal Articles

Game of clones: the genomic evolution of severe congenital neutropenia

Ivo P. Touw

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 1–7.

https://doi.org/10.1182/asheducation-2015.1.1

Published: 2015

Journal Articles

Using genetic diagnostics in hemophilia and von Willebrand disease

Laura L. Swystun, Paula James

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 152–159.

https://doi.org/10.1182/asheducation-2015.1.152

Published: 2015

Journal Articles

Emerging genetic and pharmacologic therapies for controlling hemostasis: beyond recombinant clotting factors

Paul E. Monahan

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 33–40.

https://doi.org/10.1182/asheducation-2015.1.33

Published: 2015

Journal Articles

The shadowlands of MDS: idiopathic cytopenias of undetermined significance (ICUS) and clonal hematopoiesis of indeterminate potential (CHIP)

Luca Malcovati, Mario Cazzola

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 299–307.

https://doi.org/10.1182/asheducation-2015.1.299

Published: 2015

Journal Articles

Using red blood cell genomics in transfusion medicine

Jill M. Johnsen

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 168–176.

https://doi.org/10.1182/asheducation-2015.1.168

Published: 2015

Journal Articles

Impact of MYC on malignant behavior

German Ott

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 100–106.

https://doi.org/10.1182/asheducation-2014.1.100

Published: 2014

Journal Articles

Epigenetic targeting and personalized approaches for AML

Gail J. Roboz

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 44–51.

https://doi.org/10.1182/asheducation-2014.1.44

Published: 2014

NARROW

Primary immunodeficiencies: novel genes and unusual presentations

Genetic predisposition to MDS: diagnosis and management

JAK2 (and other genes) be nimble with MPN diagnosis, prognosis, and therapy

A brief, but comprehensive, guide to clonal evolution in aplastic anemia

Potential new approaches to the management of the Hb Bart’s hydrops fetalis syndrome: the most severe form of α-thalassemia

The mutational landscape of chronic lymphocytic leukemia and its impact on prognosis and treatment

Follicular lymphoma: are we ready for a risk-adapted approach?

Acquired ribosomopathies in leukemia and solid tumors

Toward personalized treatment in Waldenström macroglobulinemia

Uncoding the genetic heterogeneity of myelodysplastic syndrome

Diagnosing von Willebrand disease: genetic analysis

Aplastic anemia and clonal evolution: germ line and somatic genetics

Ph-like acute lymphoblastic leukemia

Game of clones: the genomic evolution of severe congenital neutropenia

Using genetic diagnostics in hemophilia and von Willebrand disease

Emerging genetic and pharmacologic therapies for controlling hemostasis: beyond recombinant clotting factors

The shadowlands of MDS: idiopathic cytopenias of undetermined significance (ICUS) and clonal hematopoiesis of indeterminate potential (CHIP)

Using red blood cell genomics in transfusion medicine

Impact of MYC on malignant behavior

Epigenetic targeting and personalized approaches for AML

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only